MEDICAID-RX-MENTAL ILLNESS
Limits prior authorization and other utilization management for FDA‑approved mental illness drugs under Medicaid, speeding access with safeguards and generic substitutions allowed.
Limits prior authorization and other utilization management for FDA‑approved mental illness drugs under Medicaid, speeding access with safeguards and generic substitutions allowed.
Status & sponsor
- Sponsor: Rep. Maurice A. West, II (primary)
- Statute amended: Illinois Public Aid Code, 305 ILCS 5/5-5.12f
- Procedural highlights (from document): Passed both chambers in April 2025, transmitted to Governor; vetoed by Governor on 2025-05-02 (check official legislative site for current status). Companion: SB 1214.
Purpose / intent
- Reduce barriers and speed access to FDA‑approved prescription medications for adults with serious mental illness covered by Illinois Medical Assistance (Medicaid), by restricting the use of prior authorization (PA) mandates and other utilization management controls under fee‑for‑service and managed-care Medicaid programs.
Key provisions
- General prohibition on PA and utilization management: Medicaid programs shall not impose PA mandates or utilization management controls on any FDA‑approved prescription drug recognized by standard medical references as effective for the specified serious mental illnesses — with the limitations below.
- Applicability: The prohibition applies when a preferred or non‑preferred drug is prescribed to an adult patient to treat a listed serious mental illness, and if, during the preceding 60 days, the patient who experienced an inadequate response was prescribed and unsuccessfully treated with a 14‑day trial of a drug for the same clinical condition that appears on the preferred drug list (PDL).
- Removed conditions: The bill eliminates prior conditions that previously limited automatic coverage without PA — specifically, it removes conditioning coverage on (a) the patient changing providers while on a previously authorized drug; (b) the patient changing insurance coverage while on a previously authorized drug; and (c) the prescription merely modifying dosage or frequency of a previously authorized drug as part of the same treatment.
- Permitted safety edits and controls (not prohibited): The Department may implement clinically appropriate drug utilization review (DUR) edits (e.g., drug‑drug, drug‑age, drug‑dose), require generic substitution when an appropriate generic exists, and apply any utilization management necessary to comply with federal waivers or consent decrees.
- Definition of “serious mental illness”: The bill lists specific diagnoses (ICD‑10 codes) that qualify, including schizophrenia spectrum and other psychotic disorders, bipolar I and II, major depressive disorder (single and recurrent), PTSD, OCD, certain eating disorders, schizoaffective disorder, and related conditions. (Full list provided in bill language.)
- Federal conformity: Section clarifies it should not be construed to conflict with federal Social Security Act §1927 requirements and related regulations.
Who is affected
- Primary: Adult Medicaid enrollees (fee‑for‑service and managed care) diagnosed with a listed serious mental illness who are prescribed FDA‑approved medications for those conditions.
- Secondary: Medicaid managed‑care plans, state Medicaid program administrators (Department of Healthcare & Family Services), pharmacies, prescribers, and the state’s pharmacy benefit management processes.
- Potential fiscal impact: Reduced administrative barriers could increase medication uptake and continuity of treatment; effects on program drug spending depend on prescribing patterns, generic substitution, and utilization without PA.
Practical effect & implications
- Faster access: Limits routine PA requirements for many drugs treating serious mental illness, intending to avoid treatment delays for adults who fail a recent 14‑day trial of a PDL drug.
- Safeguards retained: State may still apply standard safety DUR rules and require generics to manage safety and costs.
- Administrative change: Managed‑care plans will need to modify PA policies and systems to align with the statutory restrictions and retained safety edits.
Notes / caveats
- The document included unrelated material from another state’s HB2438 (Arizona) concerning birth certificates. This summary focuses on the Illinois Public Aid Code changes (305 ILCS 5/5-5.12f) described in the bill text by Rep. West.
- Confirm current status and enactment (including the Governor’s veto or override actions) via the Illinois General Assembly or Secretary of State records, since procedural entries in the document indicate passage and a subsequent veto.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.